Chronic heart failure (CHF) is a common and disabling condition with morbidity and mortality
that increase dramatically with advancing age. There is some evidence available about beta …

Chronic heart failure accompanied by higher comorbidity and mortality is increasing in line
with advancing age. Previous landmark randomised clinical trials were mostly conducted in …

A meta-analysis of all-cause mortality data involving elderly and non-elderly chronic heart
failure patients from 5 completed β-blocker trials revealed that elderly and non-elderly …

Heart failure is predominantly a disease of the older person with half of all patients with the
condition aged> 75 years. Diuretics are the first-line symptomatic treatment for heart failure …

In this article different aspects of chronic heart failure in old age are described. We mainly
focus on the place of beta-blocker therapy in chronic heart failure. Beta-blockers are …

Aims Large randomized trials have shown that beta-blockers reduce mortality and hospital
admissions in patients with heart failure. The effects of beta-blockers in elderly patients with …

Beta-blocker tolerability in elderly heart failure patients - ScienceDirect Skip to main contentSkip
to article Elsevier logo Journals & Books Search RegisterSign in View PDF Download full …

Heart failure is a common and disabling condition with morbidity and mortality that increase
dramatically with advancing age. Large observational studies, retrospective subgroup …

Objectives: to evaluate how well older heart failure patients tolerate beta-blockers in
everyday clinical practice. Design: retrospective casenote analysis. Setting: specialist heart …

Most heart failure patients are older adults. Angiotensin-converting enzyme (ACE) inhibitors
reduce mortality and morbidity in patients with systolic heart failure. However, the annual …